These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Long-term treatment of porphyria cutanea tarda with low chloroquine doses. Holvay E Ther Hung; 1981; 29(1):42-6. PubMed ID: 7188240 [No Abstract] [Full Text] [Related]
27. [Chloroquine in the treatment of porphyria cutanea tarda symptomatica. Twelve years of experience in 307 patients (author's transl)]. Kordac V; Martásek P; Kaláb M; Semrádová M; Papezová R Cas Lek Cesk; 1981 Oct; 120(40):1225-7. PubMed ID: 7344792 [No Abstract] [Full Text] [Related]
28. Long-term effect of high-dose, short-course chloroquine therapy on porphyria cutanea tarda. Tsega E Q J Med; 1987 Nov; 65(247):953-7. PubMed ID: 3455550 [TBL] [Abstract][Full Text] [Related]
29. [Effect of chloroquine in porphyria cutanea tarda]. Herrero C; Muniesa A Med Cutan Ibero Lat Am; 1980; 8(4-6):139-45. PubMed ID: 7024672 [TBL] [Abstract][Full Text] [Related]
30. Management of porphyria cutanea tarda. Finnerty EF Cutis; 1977 Jul; 20(1):133-5. PubMed ID: 328230 [No Abstract] [Full Text] [Related]
31. The molecular basis of the action of chloroquine in porphyria cutanea tarda. Scholnick PL; Epstein J; Marver HS J Invest Dermatol; 1973 Oct; 61(4):226-32. PubMed ID: 4744026 [No Abstract] [Full Text] [Related]
32. Metabolic alkalinization therapy in porphyria cutanea tarda. Perry HO; Mullanax MG; Wiegand SE Arch Dermatol; 1970 Oct; 102(4):359-67. PubMed ID: 5470946 [No Abstract] [Full Text] [Related]
33. [Development of porphyria cutanea tarda after oral contraceptive therapy. Case report]. Vosmík F; Kordac V Cesk Dermatol; 1974 Oct; 49(5):298-303. PubMed ID: 4429985 [No Abstract] [Full Text] [Related]
35. [Quantitative determination of urinary porphyrins using Rimington's and Sveinsson's technic and experience in the therapy of porphyria cutanea tarda using Desferal CIBA]. Votruba M; Nozicková M; Pazderka J Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1969; 12(3):313-9. PubMed ID: 5265982 [No Abstract] [Full Text] [Related]
36. Metabolic alkalinization in porphyria cutanea tarda. Wiegand SE; Copeman PW; Perry HO Arch Dermatol; 1969 Nov; 100(5):544-9. PubMed ID: 5350406 [No Abstract] [Full Text] [Related]
37. [Porphyria cutanea tarda treated with low doses of antimalarial agents; liver findings (author's transl)]. Chlumský J; Dobiás J; Chlumská A; Malina L Cas Lek Cesk; 1977 Nov; 116(45):1404-6. PubMed ID: 603887 [No Abstract] [Full Text] [Related]
38. Porphyria Cutanea tarda in Missouri. Anderson PC Mo Med; 1981 Jun; 78(6):299-302. PubMed ID: 7254176 [No Abstract] [Full Text] [Related]
39. [Clinical and biological effects of chelating agents in porphyria cutanea tarda]. Thivolet J; Perrot H; Mallein R; Sabater P Presse Med (1893); 1968 Feb; 76(8):367-70. PubMed ID: 4967022 [No Abstract] [Full Text] [Related]
40. [Results of the therapy of porphyria cutanea tarda based on urine alkalization]. Resl V Cesk Dermatol; 1971 Dec; 46(6):249-52. PubMed ID: 5135264 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]